Matthew Stanton, CHIEF SCIENTIFIC OFFICER at Generation Bio Co. (GBIO), sold 3,000 shares at $25.51 ($75K) on 2021-07-12, disclosed to the SEC on 2021-07-14.
Scheduled sale ($75k) by CHIEF SCIENTIFIC OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.40 | 1,300 | $32K | 42.2% |
| 2 | $25.51 | 1,700 | $43K | 57.8% |
| Total | $25.03 avg | 3,000 | $75K | 100% |
| Filing → |
| GBIO | SELL | 2021-08-25 | $38K | — | Filing → |
| GBIO | SELL | 2021-08-11 | $34K | — | Filing → |
| GBIO | SELL | 2021-06-17 | $42K | — | Filing → |